SG Americas Securities LLC Cuts Stake in HealthEquity, Inc. (NASDAQ:HQY)

SG Americas Securities LLC lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 53.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,455 shares of the company's stock after selling 6,216 shares during the period. SG Americas Securities LLC's holdings in HealthEquity were worth $523,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Paladin Wealth LLC purchased a new stake in HealthEquity during the third quarter valued at $39,000. UMB Bank n.a. increased its holdings in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of HealthEquity in the 2nd quarter valued at about $73,000. GAMMA Investing LLC grew its position in HealthEquity by 57.8% in the third quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after acquiring an additional 344 shares in the last quarter. Finally, Quarry LP increased its stake in HealthEquity by 418.8% during the third quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after acquiring an additional 1,089 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada raised their price objective on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. JMP Securities boosted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. Bank of America raised their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Finally, Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of "Moderate Buy" and a consensus target price of $110.71.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now owns 66,469 shares in the company, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Frank Corvino sold 1,039 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Trading Up 1.5 %

Shares of NASDAQ HQY traded up $1.66 during trading hours on Tuesday, reaching $111.97. The stock had a trading volume of 983,431 shares, compared to its average volume of 742,161. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $113.23. The firm has a market cap of $9.70 billion, a price-to-earnings ratio of 102.72, a P/E/G ratio of 1.94 and a beta of 0.55. The business's fifty day moving average price is $100.39 and its two-hundred day moving average price is $89.02. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the company posted $0.40 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.